Sarcopenia Is a Risk Factor for Postoperative Complications Among Older Adults With Inflammatory Bowel Disease.

IF 4.5 3区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY
Ria Minawala, Michelle Kim, Olivia Delau, Ghoncheh Ghiasian, Anna Sophia McKenney, Andre Da Luz Moreira, Joshua Chodosh, Mara McAdams-DeMarco, Dorry L Segev, Samrachana Adhikari, John Dodson, Aasma Shaukat, Bari Dane, Adam S Faye
{"title":"Sarcopenia Is a Risk Factor for Postoperative Complications Among Older Adults With Inflammatory Bowel Disease.","authors":"Ria Minawala, Michelle Kim, Olivia Delau, Ghoncheh Ghiasian, Anna Sophia McKenney, Andre Da Luz Moreira, Joshua Chodosh, Mara McAdams-DeMarco, Dorry L Segev, Samrachana Adhikari, John Dodson, Aasma Shaukat, Bari Dane, Adam S Faye","doi":"10.1093/ibd/izae187","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Sarcopenia has been associated with adverse postoperative outcomes in older age cohorts, but has not been assessed in older adults with inflammatory bowel disease (IBD). Further, current assessments of sarcopenia among all aged individuals with IBD have used various measures of muscle mass as well as cutoffs to define its presence, leading to heterogeneous findings.</p><p><strong>Methods: </strong>In this single-institution, multihospital retrospective study, we identified all patients aged 60 years and older with IBD who underwent disease-related intestinal resection between 2012 and 2022. Skeletal Muscle Index (SMI) and Total Psoas Index (TPI) were measured at the superior L3 endplate on preoperative computed tomography scans and compared through receiver operating characteristic curve. We then performed multivariable logistic regression to assess risk factors associated with an adverse 30-day postoperative outcome. Our primary outcome included a 30-day composite of postoperative mortality and complications, including infection, bleeding, cardiac event, cerebrovascular accident, acute kidney injury, venous thromboembolism, reoperation, all-cause rehospitalization, and need for intensive care unit-level care.</p><p><strong>Results: </strong>A total of 120 individuals were included. Overall, 52% were female, 40% had ulcerative colitis, 60% had Crohn's disease, and median age at time of surgery was 70 years (interquartile range: 65-75). Forty percent of older adults had an adverse 30-day postoperative outcome, including infection (23%), readmission (17%), acute kidney injury (13%), bleeding (13%), intensive care unit admission (10%), cardiac event (8%), venous thromboembolism (7%), reoperation (6%), mortality (5%), and cerebrovascular accident (2%). When evaluating the predictive performance of SMI vs TPI for an adverse 30-day postoperative event, SMI had a significantly higher area under the curve of 0.66 (95% CI, 0.56-0.76) as compared to 0.58 (95% CI, 0.48-0.69) for TPI (P = .02). On multivariable logistic regression, prior IBD-related surgery (adjusted odds ratio [adjOR] 6.46, 95% CI, 1.85-22.51) and preoperative sepsis (adjOR 5.74, 95% CI, 1.36-24.17) significantly increased the odds of adverse postoperative outcomes, whereas increasing SMI was associated with a decreased risk of an adverse postoperative outcome (adjOR 0.88, 95% CI, 0.82-0.94).</p><p><strong>Conclusions: </strong>Sarcopenia, as measured by SMI, is associated with an increased risk of postoperative complications among older adults with IBD. Measurement of SMI from preoperative imaging can help risk stratify older adults with IBD undergoing intestinal resection.</p>","PeriodicalId":13623,"journal":{"name":"Inflammatory Bowel Diseases","volume":null,"pages":null},"PeriodicalIF":4.5000,"publicationDate":"2024-08-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Inflammatory Bowel Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/ibd/izae187","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Sarcopenia has been associated with adverse postoperative outcomes in older age cohorts, but has not been assessed in older adults with inflammatory bowel disease (IBD). Further, current assessments of sarcopenia among all aged individuals with IBD have used various measures of muscle mass as well as cutoffs to define its presence, leading to heterogeneous findings.

Methods: In this single-institution, multihospital retrospective study, we identified all patients aged 60 years and older with IBD who underwent disease-related intestinal resection between 2012 and 2022. Skeletal Muscle Index (SMI) and Total Psoas Index (TPI) were measured at the superior L3 endplate on preoperative computed tomography scans and compared through receiver operating characteristic curve. We then performed multivariable logistic regression to assess risk factors associated with an adverse 30-day postoperative outcome. Our primary outcome included a 30-day composite of postoperative mortality and complications, including infection, bleeding, cardiac event, cerebrovascular accident, acute kidney injury, venous thromboembolism, reoperation, all-cause rehospitalization, and need for intensive care unit-level care.

Results: A total of 120 individuals were included. Overall, 52% were female, 40% had ulcerative colitis, 60% had Crohn's disease, and median age at time of surgery was 70 years (interquartile range: 65-75). Forty percent of older adults had an adverse 30-day postoperative outcome, including infection (23%), readmission (17%), acute kidney injury (13%), bleeding (13%), intensive care unit admission (10%), cardiac event (8%), venous thromboembolism (7%), reoperation (6%), mortality (5%), and cerebrovascular accident (2%). When evaluating the predictive performance of SMI vs TPI for an adverse 30-day postoperative event, SMI had a significantly higher area under the curve of 0.66 (95% CI, 0.56-0.76) as compared to 0.58 (95% CI, 0.48-0.69) for TPI (P = .02). On multivariable logistic regression, prior IBD-related surgery (adjusted odds ratio [adjOR] 6.46, 95% CI, 1.85-22.51) and preoperative sepsis (adjOR 5.74, 95% CI, 1.36-24.17) significantly increased the odds of adverse postoperative outcomes, whereas increasing SMI was associated with a decreased risk of an adverse postoperative outcome (adjOR 0.88, 95% CI, 0.82-0.94).

Conclusions: Sarcopenia, as measured by SMI, is associated with an increased risk of postoperative complications among older adults with IBD. Measurement of SMI from preoperative imaging can help risk stratify older adults with IBD undergoing intestinal resection.

肌肉疏松症是患有炎症性肠病的老年人术后并发症的一个风险因素。
背景:肌肉疏松症与老年人群的术后不良预后有关,但尚未对患有炎症性肠病(IBD)的老年人进行评估。此外,目前对所有患有 IBD 的老年患者进行的肌肉疏松症评估都使用了不同的肌肉质量测量方法和截断值来定义肌肉疏松症的存在,从而导致了不同的评估结果:在这项单机构、多医院的回顾性研究中,我们确定了所有在2012年至2022年期间接受疾病相关肠道切除术的60岁及以上IBD患者。我们在术前计算机断层扫描L3上端板处测量了骨骼肌指数(SMI)和腰肌总指数(TPI),并通过接收器操作特征曲线进行了比较。然后,我们进行了多变量逻辑回归,以评估与术后 30 天不良预后相关的风险因素。我们的主要结果包括术后30天死亡率和并发症(包括感染、出血、心脏事件、脑血管意外、急性肾损伤、静脉血栓栓塞、再次手术、全因再次住院以及需要重症监护室级别的护理)的综合结果:共纳入 120 人。总体而言,52%为女性,40%患有溃疡性结肠炎,60%患有克罗恩病,手术时的中位年龄为70岁(四分位距:65-75岁)。40%的老年人术后 30 天出现不良后果,包括感染(23%)、再次入院(17%)、急性肾损伤(13%)、出血(13%)、入住重症监护室(10%)、心脏事件(8%)、静脉血栓栓塞(7%)、再次手术(6%)、死亡率(5%)和脑血管意外(2%)。在评估 SMI 与 TPI 对术后 30 天不良事件的预测性能时,SMI 的曲线下面积为 0.66(95% CI,0.56-0.76),显著高于 TPI 的 0.58(95% CI,0.48-0.69)(P = 0.02)。在多变量逻辑回归中,既往接受过 IBD 相关手术(调整后比值比 [adjOR] 6.46,95% CI,1.85-22.51)和术前败血症(调整后比值比 [adjOR] 5.74,95% CI,1.36-24.17)会显著增加术后不良预后的几率,而 SMI 的增加与术后不良预后风险的降低有关(调整后比值比 [adjOR] 0.88,95% CI,0.82-0.94):结论:以 SMI 衡量的 "肌肉疏松症 "与患有 IBD 的老年人术后并发症风险增加有关。通过术前成像测量 SMI 可帮助对接受肠切除术的 IBD 老年患者进行风险分层。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Inflammatory Bowel Diseases
Inflammatory Bowel Diseases 医学-胃肠肝病学
CiteScore
9.70
自引率
6.10%
发文量
462
审稿时长
1 months
期刊介绍: Inflammatory Bowel Diseases® supports the mission of the Crohn''s & Colitis Foundation by bringing the most impactful and cutting edge clinical topics and research findings related to inflammatory bowel diseases to clinicians and researchers working in IBD and related fields. The Journal is committed to publishing on innovative topics that influence the future of clinical care, treatment, and research.
文献相关原料
公司名称 产品信息 采购帮参考价格
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信